Aber das Unternehmen hat doch dumm gesagt nichts falsch gemacht oder? Die haben ja ein reales Geschäft also kann auch diese Horrornachricht doch nicht das Unternehmen ausschalten? Von wegen Totalverlust und so??
•
11
•
@PikaPika0105 naja eine Festnahme ist schon eine andere Hausnummer , scheinbar doch nicht alles korrekt
••
@Nemesis1990 also gut laufen tut da nicht alles, aber das Geschäft existiert ja trotzdem und die Partner wie Henkel. Gestern gab es doch auch erst News zu den chinesischen Partnern.
•
11
•@PikaPika0105 ob die alle wahr sind ? Man weiß es nicht , können nur beobachten …. Sollte sie wieder handelbar sein Verkauf ich sofort .
•
11
•@Nemesis1990 das ließe sich ja sehr leicht überprüfen und wenn Nachrichtenhäuser darüber berichten würden und es nicht stimmt, hätten sich besagte Firmen bestimmt auch längst gemeldet.
••
@PikaPika0105 das ist die gute Annahme. Die Wahrscheinlichlichere ist leider, dass der CEO Briefkastenfirmen über Mittelsmänner gegründet hat und es diese Geschäfte nicht gibt.
••
@Multibagger Das halte ich für unwahrscheinlich. Wenn die Geschäfte nicht existieren würden hätten das Henkel und Likang wohl bereits angemerkt.
Das ist ein Artikel von vor zwei Tagen zur Partnerschaft mit den Chinesen:
Intellego Technologies AB ("Intellego") announces that its partner, Shanghai Zhongyou Medical High Tech Co., Ltd ("LiKang"), continues to purchase Intellego's UV dosimeter products in China following positive feedback from the market. These purchases relate to Intellego's standardized UV dosimeters which are not classified as medical devices. LiKang has been selling Intellego's standard dosimeter products during the past year, and more than 1,000 hospitals have started to implement Intellego's products to quality-assure UV disinfection processes.
The use of UV disinfection is currently subject to a regulatory revision in China, which is expected to make the use of verification products such as Intellego's dosimeters mandatory. These factors, combined with strong market feedback and a growing customer base, have contributed to LiKang's increased order activity.
November 2025, Intellego's CEO, Claes Lindahl, and Chairman of the Board, Gregory Batcheller, visited LiKang in China to discuss the ongoing collaboration and future expansion. Over the past year, LiKang has carried out extensive market development work and collected substantial feedback from end users, indicating strong customer satisfaction and market potential:
95% of hospitals use colour indicators to verify UV exposure levels, while 3% use radiometers.
Approximately 88% of users of Intellego's dosimeters report being very satisfied with the products.
Around 60% consider Intellego's dosimeters significantly better than competing products, 35% find them somewhat better, and 5% rated Intellego's products below the competition.
Intellego's dosimeters are now in use at more than 1,000 hospitals in China.
A dedicated app system for the disinfection market is under review.
Regulatory revision expected in 2026, which would make the use of verification products like Intellego's mandatory on a continuous basis.
For 2026 and onwards, the sales will continue to increase based on the estimation that a hospital will spend between USD 10,000 and 20,000 per month on colour indicators to verify UV disinfection.
Das ist ein Artikel von vor zwei Tagen zur Partnerschaft mit den Chinesen:
Intellego Technologies AB ("Intellego") announces that its partner, Shanghai Zhongyou Medical High Tech Co., Ltd ("LiKang"), continues to purchase Intellego's UV dosimeter products in China following positive feedback from the market. These purchases relate to Intellego's standardized UV dosimeters which are not classified as medical devices. LiKang has been selling Intellego's standard dosimeter products during the past year, and more than 1,000 hospitals have started to implement Intellego's products to quality-assure UV disinfection processes.
The use of UV disinfection is currently subject to a regulatory revision in China, which is expected to make the use of verification products such as Intellego's dosimeters mandatory. These factors, combined with strong market feedback and a growing customer base, have contributed to LiKang's increased order activity.
November 2025, Intellego's CEO, Claes Lindahl, and Chairman of the Board, Gregory Batcheller, visited LiKang in China to discuss the ongoing collaboration and future expansion. Over the past year, LiKang has carried out extensive market development work and collected substantial feedback from end users, indicating strong customer satisfaction and market potential:
95% of hospitals use colour indicators to verify UV exposure levels, while 3% use radiometers.
Approximately 88% of users of Intellego's dosimeters report being very satisfied with the products.
Around 60% consider Intellego's dosimeters significantly better than competing products, 35% find them somewhat better, and 5% rated Intellego's products below the competition.
Intellego's dosimeters are now in use at more than 1,000 hospitals in China.
A dedicated app system for the disinfection market is under review.
Regulatory revision expected in 2026, which would make the use of verification products like Intellego's mandatory on a continuous basis.
For 2026 and onwards, the sales will continue to increase based on the estimation that a hospital will spend between USD 10,000 and 20,000 per month on colour indicators to verify UV disinfection.
••
@PikaPika0105 wenn das gelogen wäre und keiner sich bemüht das zu korrigieren, wäre das schon wild
••
@PikaPika0105 ich fände es toll wenn Du Recht hast, es könnte aber auch so sein, wie im Video angedeutet.
https://youtu.be/P2AoVylmOaI?si=g-QOaYcQ8QYKx310
https://youtu.be/P2AoVylmOaI?si=g-QOaYcQ8QYKx310
••
@Multibagger das ist ja älter als dein erster Beitrag zu denen…… Gucke ich mir mal an.
•
11
•@PikaPika0105 ja, er hat noch einen aktuellen in seiner App gemacht gestern. Den kann ich aber leider nicht kopieren.
••